Jintian Pharmaceutical Group Limited provided earnings guidance for the six months ended June 30, 2014. For the six months, the company expects to record a substantial increase in its consolidated net profit for the six months ended 30 June 2014 as compared to that for the corresponding period in 2013, which is mainly attributable to a substantial growth in both the retail and distribution businesses.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.067 HKD | 0.00% | +42.55% | -32.32% |
1st Jan change | Capi. | |
---|---|---|
-32.32% | 5.73M | |
+19.13% | 71.69B | |
-3.66% | 23.65B | |
+8.80% | 9.01B | |
+11.24% | 8.64B | |
-18.91% | 8.15B | |
+16.00% | 5.33B | |
+17.83% | 4.35B | |
-2.11% | 4.1B | |
-1.72% | 3.94B |
- Stock Market
- Equities
- 2211 Stock
- News Universal Health International Group Holding Limited
- Jintian Pharmaceutical Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2014